These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32903251)

  • 1. Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.
    Bishop MR
    Clin Adv Hematol Oncol; 2020 Jul; 18(7):400-403. PubMed ID: 32903251
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 pneumonia: CD8
    Jiang Y; Wei X; Guan J; Qin S; Wang Z; Lu H; Qian J; Wu L; Chen Y; Chen Y; Lin X
    Clin Immunol; 2020 Sep; 218():108516. PubMed ID: 32574709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
    Prete M; Favoino E; Catacchio G; Racanelli V; Perosa F
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immune responses to covid-19.
    Sewell HF; Agius RM; Stewart M; Kendrick D
    BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing patients with hematological malignancies during COVID-19 pandemic.
    Sahu KK; Cerny J
    Expert Rev Hematol; 2020 Aug; 13(8):787-793. PubMed ID: 32580592
    [No Abstract]   [Full Text] [Related]  

  • 7. Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation.
    Mack AH; Schofield HL
    Psychosomatics; 2020; 61(6):859-860. PubMed ID: 32739050
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
    Bouadma L; Wiedemann A; Patrier J; Surénaud M; Wicky PH; Foucat E; Diehl JL; Hejblum BP; Sinnah F; de Montmollin E; Lacabaratz C; Thiébaut R; Timsit JF; Lévy Y
    J Clin Immunol; 2020 Nov; 40(8):1082-1092. PubMed ID: 32829467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a "Cytokine Storm" Relevant to COVID-19?
    Sinha P; Matthay MA; Calfee CS
    JAMA Intern Med; 2020 Sep; 180(9):1152-1154. PubMed ID: 32602883
    [No Abstract]   [Full Text] [Related]  

  • 10. Extracorporeal Hemoadsorption: An Option for COVID-19-Associated Cytokine Storm Syndrome.
    Napp LC; Bauersachs J
    Shock; 2020 Nov; 54(5):700-701. PubMed ID: 32453251
    [No Abstract]   [Full Text] [Related]  

  • 11. A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients.
    Roncati L; Ligabue G; Nasillo V; Lusenti B; Gennari W; Fabbiani L; Malagoli C; Gallo G; Giovanella S; Lupi M; Salviato T; Paolini A; Costantini M; Trenti T; Maiorana A
    Platelets; 2020 Nov; 31(8):1085-1089. PubMed ID: 32857624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plea for the pathogenic role of immune complexes in severe Covid-19.
    Vuitton DA; Vuitton L; Seillès E; Galanaud P
    Clin Immunol; 2020 Aug; 217():108493. PubMed ID: 32526273
    [No Abstract]   [Full Text] [Related]  

  • 14. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.
    Hanley B; Roufosse CA; Osborn M; Naresh KN
    Br J Haematol; 2020 Jun; 189(6):1062-1063. PubMed ID: 32369628
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
    Abid MB; Mughal M; Abid MA
    JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.
    Lee WS; Margolskee E
    Blood; 2020 Aug; 136(7):914. PubMed ID: 32790856
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
    Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
    Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
    Xi Y
    Signal Transduct Target Ther; 2020 Sep; 5(1):203. PubMed ID: 32934211
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
    Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
    Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
    Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
    Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.